Laura Chirica appointed new Board Director in Gradientech
Uppsala, 6 September 2021. The Extra General Meeting at the diagnostic company Gradientech today elected Laura Chirica new Board Director. Laura has 20 years of experience from leading positions within life science, bio process and diagnostic companies, and is currently Chief Commercial Officer at Immunovia AB.“Laura Chirica has played a key role in the commercialization of Immunovia’s first product, being part of the company’s journey from the beginning until reaching market. During these years, Immunovia was approved for trading in 2015 on Nasdaq First North in Stockholm followed by